|
C13ORF23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.174200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.656800E-03 |
| Normal-vs-Stage2 |
7.785700E-02 |
| Normal-vs-Stage3 |
7.90900000000594E-05 |
| Normal-vs-Stage4 |
2.177200E-03 |
| Stage1-vs-Stage2 |
8.341800E-01 |
| Stage1-vs-Stage3 |
3.389600E-02 |
| Stage1-vs-Stage4 |
1.661650E-01 |
| Stage2-vs-Stage3 |
2.388400E-01 |
| Stage2-vs-Stage4 |
4.501600E-01 |
| Stage3-vs-Stage4 |
7.073000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.180300E-04 |
| Normal-vs-AfricanAmerican |
1.055460E-03 |
| Normal-vs-Asian |
5.449600E-01 |
| Caucasian-vs-AfricanAmerican |
2.235400E-01 |
| Caucasian-vs-Asian |
1.324050E-01 |
| AfricanAmerican-vs-Asian |
5.671600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.150830E-04 |
| Normal-vs-Female |
2.408100E-02 |
| Male-vs-Female |
7.734300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.135900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.784900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.427500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.665800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.885000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.138600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.146000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.862650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.075000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.131400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.238200E-01 |
| Normal-vs-Grade 2 |
2.335700E-02 |
| Normal-vs-Grade 3 |
4.02170000000091E-05 |
| Normal-vs-Grade 4 |
2.061800E-03 |
| Grade 1-vs-Grade 2 |
8.302300E-02 |
| Grade 1-vs-Grade 3 |
7.376000E-03 |
| Grade 1-vs-Grade 4 |
2.465700E-02 |
| Grade 2-vs-Grade 3 |
2.444400E-02 |
| Grade 2-vs-Grade 4 |
9.776100E-02 |
| Grade 3-vs-Grade 4 |
9.043000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.063800E-01 |
| Normal-vs-ccB subtype |
6.45379999999474E-05 |
| ccA subtype-vs-ccB subtype |
4.003700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.701500E-03 |
| Normal-vs-N1 |
3.476400E-01 |
| N0-vs-N1 |
9.992200E-01 |
|
|
